The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(3-Iodophenyl)-6-(4-methylpiperazin-1-yl)pyrimidin-2-ylamine ID: ALA442865
PubChem CID: 25129877
Max Phase: Preclinical
Molecular Formula: C15H18IN5
Molecular Weight: 395.25
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CN1CCN(c2cc(-c3cccc(I)c3)nc(N)n2)CC1
Standard InChI: InChI=1S/C15H18IN5/c1-20-5-7-21(8-6-20)14-10-13(18-15(17)19-14)11-3-2-4-12(16)9-11/h2-4,9-10H,5-8H2,1H3,(H2,17,18,19)
Standard InChI Key: UIAFEYRHHDAHSN-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
15.3230 -17.5398 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.3218 -18.3666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0363 -18.7793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7522 -18.3662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7493 -17.5361 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.0345 -17.1272 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4646 -18.7765 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.4639 -19.6020 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1745 -20.0130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8904 -19.6032 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.8911 -18.7777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1759 -18.3621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6035 -20.0170 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0320 -16.3027 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.6094 -18.7786 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8953 -18.3641 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1814 -18.7751 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1803 -19.6005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8991 -20.0131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6101 -19.5998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9014 -20.8377 0.0000 I 0 0 0 0 0 0 0 0 0 0 0 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
4 7 1 0
6 1 1 0
10 13 1 0
7 8 1 0
6 14 1 0
1 2 2 0
3 4 2 0
15 16 2 0
16 17 1 0
4 5 1 0
17 18 2 0
2 3 1 0
18 19 1 0
5 6 2 0
19 20 2 0
20 15 1 0
2 15 1 0
7 12 1 0
19 21 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 395.25Molecular Weight (Monoisotopic): 395.0607AlogP: 2.08#Rotatable Bonds: 2Polar Surface Area: 58.28Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 7.61CX LogP: 3.41CX LogD: 2.96Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.79Np Likeness Score: -1.81
References 1. Altenbach RJ, Adair RM, Bettencourt BM, Black LA, Fix-Stenzel SR, Gopalakrishnan SM, Hsieh GC, Liu H, Marsh KC, McPherson MJ, Milicic I, Miller TR, Vortherms TA, Warrior U, Wetter JM, Wishart N, Witte DG, Honore P, Esbenshade TA, Hancock AA, Brioni JD, Cowart MD.. (2008) Structure-activity studies on a series of a 2-aminopyrimidine-containing histamine H4 receptor ligands., 51 (20): [PMID:18811133 ] [10.1021/jm8005959 ]